Melanotan II (MT2)

Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that triggers melanin production in skin cells. Originally developed by researchers at the University of Arizona as a potential preventive treatment for skin cancer—theorizing that increased melanin could protect against UV damage—the peptide proved highly effective at producing tans but also demonstrated unexpected effects on sexual function and appetite. This combination has made it popular among those seeking tanning without extensive sun exposure, though it remains unapproved by the FDA and carries real risks including mole changes that require monitoring. The compound works by activating melanocortin receptors throughout the body, producing its diverse effects on pigmentation, sexual arousal, and feeding behavior.

Quickstart Highlights

Melanotan II is a synthetic analog of α-melanocyte-stimulating hormone studied for its ability to increase skin pigmentation and noted for inducing erectile activity as a side effect^[1]. Early human trials identified effective daily doses in the range of 1–2 mg for tanning, with conservative protocols starting lower to minimize side effects such as nausea and flushing^[2][3].

How It Works

Melanotan II is a synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone that binds to melanocortin receptors, particularly MC1R and MC4R^[1]. Activation of MC1R on melanocytes stimulates melanin production and distribution, resulting in increased skin pigmentation even without UV exposure^[2]. Early Phase I studies in humans identified 0.025 mg/kg per day (approximately 1.5–2 mg for an average adult) as an appropriate dose, with measurable tanning observed after just five low doses administered over two weeks^[1]. The peptide’s subcutaneous administration allows for steady melanocortin receptor activation, with effects accumulating over the course of daily injections during the initial tanning phase^[3].

Potential Benefits & Side Effects

Observations from clinical trials and case reports.

Potential Benefits

• Increases skin pigmentation (tanning) without UV exposure requirement^[1][2].
• Tanning effects observable after 5–10 daily injections in most individuals^[1].
• May induce spontaneous erections in men as a noted side effect (MC4R activation)^[3][5].
• Maintenance dosing (1–2× weekly) can sustain pigmentation after initial loading phase^[3].

Common Side Effects

• Nausea (dose-dependent; most common at higher doses)^[1][2].
• Facial flushing and increased skin warmth^[3].
• Reduced appetite and mild fatigue^[1].
• Spontaneous erections or increased libido in men^[5].
• Injection site reactions (redness, mild stinging)^[9].

Serious Risks & Warnings

• Not FDA-approved: Melanotan II is not an approved medication; use carries regulatory and safety risks^[6].
• Dose-limiting toxicity: Severe sympathomimetic symptoms and rhabdomyolysis reported at 6 mg dose^[4].
• Mole changes: May alter pigmentation of existing moles; theoretical melanoma concerns warrant caution^[6].
• Cardiovascular effects: Transient increases in heart rate and blood pressure possible at higher doses^[3].

References

• PubMed — Dorr RT et al. (1996)Phase I clinical study of melanotan-II, evaluation of dosing and safety in healthy volunteers
• International Peptide Society — Melanotan II MonographComprehensive peptide monograph covering dosing protocols and titration guidance
• DermNet NZ — Melanotan II Information for PatientsClinical dermatology guidance on melanotan use, side effects, and maintenance dosing
• PubMed — Nelson ME et al. (2012)Case report: Melanotan II injection resulting in systemic toxicity and rhabdomyolysis
• RxList — Melanotan-II Uses, Side Effects and DosingMedical database overview of melanotan-II pharmacology and clinical effects
• Cell Sciences Inc. — Product Data SheetMelanotan-II storage and stability specifications for lyophilized and reconstituted forms
• MedlinePlus — Subcutaneous InjectionsU.S. National Library of Medicine patient instructions for subcutaneous injection technique
• NCBI Bookshelf — Administration of Parenteral MedicationsComprehensive nursing guide for safe injection practices and sterile technique
• CDC — Vaccine Administration GuidelinesSubcutaneous injection technique, site selection, and best practices from the CDC
• NCBI Bookshelf — Best Practices for Injection SafetyClinical guidelines for aseptic preparation and administration of injectable medications